* marker ul cancerului de prostata

July 1, 2010 — New data from a Swedish study show that population screening with prostate-specific antigen (PSA) in men between 50 and 69 years of age reduced prostate cancer mortality by almost half during a follow-up period of 14 years. The finding was published online today in Lancet Oncology.

No comments:

HOME (*Revenire-Pagina la Zi)